The goal of this clinical trial is to validate the interest of a strategy adjusting the flow rate delivered under high-flow oxygen (HFO) therapy according to the lung volumes measured by a new technique, in intensive care patients with hypoxemic respiratory distress (HRD). The main question it aims to answer is: "The use of a technique of measurement of lung pulmonary with adjustement to the flow rate can make it possible to limite intubation in patients with HRD in intensive care?" The participants will be the patients admitted in intensive care for HRD with the need for treatment with HFO. This participants will be randomized in : * the arm control: treated by high flow oxygen therapy according to standard procedures. * or in the experimental arm : treated by high flow oxygen therapy with adjustement of ventilatory parametres based on lung volume measurements, obtained by the depth camera.
High-flow oxygen therapy (HFO) is a common technique for the management of patient with hypoxemic respiratory distress in intensive care.The variations in lung volumes induced by the HFO in patients is unknown in clinical routine, in the absence of the availability of a effective measurement technique. The investigators research team validated a new non-invasive, non-contact technique for measuring lung volumes using depth camera. Using a stereoscopic camera, the patient's chest and abdomen are recognized by a artificial intelligence algorithms. The structures of interest of the chest and the abdomen are the identified and the variation in depth of these points in space allows both the integration of lung volume through automatic calibration procedures, the measurement of respiratory rate and comparaison of movement symetries.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
406
Use of a technique based on non-contact measurement of lung volumes by depth camera in order to optimise the use of hihg flow oxygen therapy, with adaptation of the flow rate.
Brest, University Hospital
Brest, France
RECRUITINGAP-HP - Hôpital Louis Mourier
Colombes, France
NOT_YET_RECRUITINGAP-HP - Hôpital Henri Mondor
Créteil, France
NOT_YET_RECRUITINGCH Morlaix
Morlaix, France
NOT_YET_RECRUITINGCHR Orléans
Orléans, France
NOT_YET_RECRUITINGCH Poitiers
Poitiers, France
NOT_YET_RECRUITINGCHU Rennes
Rennes, France
NOT_YET_RECRUITINGCHU Tours
Tours, France
NOT_YET_RECRUITINGUse of intubation within 28 days of randomization
Collection of the use of intubation (Yes/No) in patients
Time frame: from patient randomization to day 90
Evaluation of organ dysfunction
daily SOFA score
Time frame: up to 28 days after randomization
Evaluation of respiratory therapy
daily ROX Index
Time frame: up to 28 days after randomization
Reduced need for ventilatory techniques
Number of days without ventilatory support
Time frame: from inclusion to day 28
Mortality
Number of death
Time frame: 90 days after inclusion
Collection of data on clinicians' acceptance of the technique and on ergonomics
Evaluation of ergonomy by the System Usability Scale (SUS). The SUS is based on a Likert scale that allows the user to respond on a 5-point scale from 1:'Strongly disagree' to 5:'Strongly agree'.
Time frame: from patient inclusion to day 90
Collection of data on clinicians' acceptance of the technique and on ergonomics
Evaluation of load task by NASA-TLX index
Time frame: from patient inclusion to day 90
Assessment of patient comfort under high oxygen flow
EVA scale
Time frame: up to 28 days after randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.